Valuation: ConvaTec Group

Market Cap 559.4Cr 487.8Cr 460.59Cr 418.25Cr 783.64Cr 54TCr 786.91Cr 5.52TCr 2.13TCr 27TCr 2.1TCr 2.05TCr 88TCr P/E 2026 *
22.2x
P/E 2027 * 15.2x
Enterprise Value 699.65Cr 610.09Cr 576.07Cr 523.11Cr 980.1Cr 67TCr 984.2Cr 6.9TCr 2.66TCr 34TCr 2.63TCr 2.57TCr 1,09800Cr EV / Sales 2026 *
2.74x
EV / Sales 2027 * 2.49x
Free-Float
95.12%
Yield 2026 *
2.78%
Yield 2027 * 3.18%
Manager TitleAgeSince
Chief Executive Officer 62 04/08/2025
Director of Finance/CFO 51 04/08/2025
Chief Operating Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 71 14/08/2017
Chairman 78 30/09/2019
Director/Board Member 62 02/03/2020
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 559.4Cr
+0.37%+0.65%-23.75%+1.59% 18TCr
-0.69%+1.29%-3.62%+11.27% 12TCr
-0.20%-3.98%+6.17%+72.47% 5.89TCr
-0.24%+1.74%-3.94%-31.61% 4.93TCr
-0.22%-0.37%+7.26%+35.20% 4.82TCr
+1.61%+7.61%+17.91%-6.24% 3.37TCr
-1.49%-2.74% - - 2.78TCr
-1.17%+4.64%+42.09%-8.18% 2.55TCr
+1.02%+5.99%+7.20%-19.54% 2.21TCr
Average -0.10%+1.85%+6.16%+6.87% 6.23TCr
Weighted average by Cap. -0.08%+1.03%-4.29%+9.69%

Financials

2026 *2027 *
Net sales 255.47Cr 222.77Cr 210.34Cr 191.01Cr 357.87Cr 25TCr 359.37Cr 2.52TCr 972.31Cr 12TCr 959.66Cr 938.36Cr 40TCr 273.33Cr 238.34Cr 225.05Cr 204.36Cr 382.9Cr 26TCr 384.49Cr 2.7TCr 1.04TCr 13TCr 1.03TCr 1TCr 43TCr
Net income 25Cr 22Cr 21Cr 19Cr 35Cr 2.4TCr 35Cr 246.43Cr 95Cr 1.22TCr 94Cr 92Cr 3.92TCr 36Cr 32Cr 30Cr 27Cr 51Cr 3.5TCr 51Cr 359.96Cr 138.91Cr 1.78TCr 137.1Cr 134.06Cr 5.73TCr
Net Debt 140.25Cr 122.3Cr 115.48Cr 104.86Cr 196.47Cr 13TCr 197.29Cr 1.38TCr 533.78Cr 6.84TCr 526.84Cr 515.14Cr 22TCr 122.37Cr 106.71Cr 100.76Cr 91Cr 171.43Cr 12TCr 172.14Cr 1.21TCr 465.76Cr 5.97TCr 459.7Cr 449.5Cr 19TCr
Logo ConvaTec Group
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!